For adults with severe alopecia areata (AA), ivarmacitinib, a selective Janus kinase 1 (JAK1) inhibitor, at doses of 4 and 8 mg is efficacious and tolerable, according to a study presented at the annual meeting of the American Academy of Dermatology, held from March 7 to 11 in Orlando, Florida.
Researchers from the University of Seville and the University of Cadiz, coordinated by the professors of Physiology Pedro Núñez-Abades and Carmen Castro, have demonstrated that the use of diterpenes facilitates repopulation with new neurons in brain regions damaged by traumatic injuries.
For current and former smokers, statins may reduce the amount of chest muscle loss, while aspirin may contribute to increased chest muscle loss, according to a new study. The study is published in the January 2025 issue of Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation.
Researchers at Case Western Reserve University have discovered molecules that present the potential to drive the development of gastric cancer—among the world’s deadliest forms of the disease.
For residents of Kibera, one of Nairobi’s largest informal settlements, access to nutritious food is often scarce. School meals are a lifeline for many families. But the case study of one small school is proving that—with the right ingredients—school meal programs can become even more beneficial.
Denoised ultra-low-dose CT can effectively diagnose pneumonia in immunocompromised patients using only 2% of the radiation dose of standard CT, according to a study published in Radiology: Cardiothoracic Imaging.
The rapid digitization of essential services in the U.K. is deepening inequalities for minoritzed ethnic communities, a major three-year research project has found.
More than 90,000 people are on the waiting list for a kidney in the U.S. Unfortunately, less than a third of those waiting for a kidney transplant can expect to get one this year. This comes as rates of chronic kidney disease, which can lead to kidney failure, continue to climb across the globe. But there is a way to help. Healthy people can donate one of their kidneys, giving someone a much-needed second chance.
A new study led by Jonathan D. Santoro, MD, Director of the Neuroimmunology Program at Children’s Hospital Los Angeles, shows evidence of dysfunction of the blood–brain barrier and inflammation in the central nervous system in individuals with Down syndrome regression disorder (DSRD).
At night, Alex Mercado could feel the walls closing in. The 28-year-old living in Dallas, far from his family in Ciudad Juarez, struggled with insomnia.